Therapeutically active fluoro substituted benzimidazoles
    3.
    发明授权
    Therapeutically active fluoro substituted benzimidazoles 失效
    治疗活性氟取代的苯并咪唑

    公开(公告)号:US5441968A

    公开(公告)日:1995-08-15

    申请号:US134255

    申请日:1993-10-08

    IPC分类号: C07D401/12 A61K31/44

    CPC分类号: C07D401/12

    摘要: The novel compounds of the formulas I and I' ##STR1## wherein F is in 5 or 6 position and ##STR2## wherein in both formulas R is the group --CH.sub.2 OCOOR.sup.1, wherein R.sup.1 is a straight or branched alkyl containing 1-6 carbon atoms or benzyl, or R.sup.1 is the group ##STR3## wherein n is 1-6 and physiologically acceptable salts thereof as well as intermediates, pharmaceutical compositions containing such compounds as active ingredient, and the use of the compounds in medicine.

    摘要翻译: 式I和I'的新颖化合物,其中F为5或6位且其中在两式中,R为基团-CH 2 OCOOR 1,其中R 1为含有1- 6个碳原子或苄基,或R1是其中n是1-6的基团,或其生理学上可接受的盐以及中间体,含有这些化合物作为活性成分的药物组合物,以及该化合物的用途 在医学上。

    Therapeutically active fluoro substituted benzimidazoles
    4.
    发明授权
    Therapeutically active fluoro substituted benzimidazoles 失效
    治疗活性氟取代的苯并咪唑

    公开(公告)号:US5274099A

    公开(公告)日:1993-12-28

    申请号:US596984

    申请日:1990-12-07

    IPC分类号: C07D401/12

    CPC分类号: C07D401/12

    摘要: The novel compounds of the formulas I and I' ##STR1## wherein F is in 5 or 6 position and ##STR2## wherein in both formulas R is the group --CH.sub.2 OCOOR.sup.1, wherein R.sup.1 is a straight or branched alkyl containing 1-6 carbon atoms or benzyl, or R.sup.1 is the group --(CH.sub.2).sub.n ##STR3## --(CH.sub.2).sub.n COOH or --(CH.sub.2).sub.n SO.sub.3 H wherein n is 1-6 and physiologically acceptable salts thereof as well as intermediates, pharmaceutical compositions containing such compounds as active ingredient, and the use of the compounds in medicine.

    摘要翻译: 式I和I'的新颖化合物,其中F为5或6位且其中在两式中,R为基团-CH 2 OCOOR 1,其中R 1为含有1- 6个碳原子或苄基,或者R1是基团 - (CH 2)n COOH或 - (CH 2)n SO 3 H,其中n是1-6及其生理上可接受的盐以及中间体,药物组合物 含有作为活性成分的化合物,以及该化合物在医药中的用途。

    Dialkoxy-pyridinyl-benzimidazole derivatives, process for their
preparation and their pharmaceutical use
    7.
    发明授权
    Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use 失效
    二烷氧基 - 吡啶基 - 苯并咪唑衍生物,其制备方法及其药物用途

    公开(公告)号:US5430042A

    公开(公告)日:1995-07-04

    申请号:US718188

    申请日:1991-06-20

    摘要: The novel compounds of the formula I ##STR1## and physiologically acceptable salts thereof, wherein R.sup.1 and R.sup.2, which are different is each H alkyl containing 1-4 carbon atoms or --C(O)--R.sup.5 ;whereinR.sup.5 is alkyl containing 1-4 carbon atoms or alkoxy containing 1-4 carbon atoms and one of R.sup.1, or R.sup.2 is always selected from the group --C(O)--R.sup.5 ;R.sup.3 and R.sup.4 are the same or different and selected from ##STR2## and --CH.sub.2 CH.sub.2 OCH.sub.3 or R.sup.3 and R.sup.4 together with the adjacent oxygen atoms atached to the pyridine ring and the carbon atoms in the pyridine ring form a ring, wherein the part constituted by R.sup.3 and R.sup.4 is --CH.sub.2 CH.sub.2 CH.sub.2 --, or --CH.sub.2 --CH.sub.2 -- or --CH.sub.2 --; as well as intermediates, pharmaceutical compositions containing such compounds as active ingredient and the use of the compounds in medicine.

    摘要翻译: 式I的新化合物Ⅰ及其生理上可接受的盐,其中不同的R 1和R 2各自为含有1-4个碳原子的烷基或-C(O)-R 5; 其中R 5是含有1-4个碳原子的烷基或含有1-4个碳原子的烷氧基,R 1或R 2中的一个总是选自基团-C(O)-R 5; R3和R4相同或不同,并且选自< IMAGE>和-CH 2 CH 2 OCH 3或R 3和R 4以及与吡啶环相邻的相邻氧原子,吡啶环中的碳原子形成环,其中由R3构成的部分 和R 4是-CH 2 CH 2 CH 2 - ,或-CH 2 -CH 2 - 或-CH 2 - ; 以及中间体,含有这些化合物作为活性成分的药物组合物和该化合物在医药中的用途。

    Therapeutically active fluoro substituted benzimidazoles
    8.
    发明授权
    Therapeutically active fluoro substituted benzimidazoles 失效
    治疗活性氟取代的苯并咪唑

    公开(公告)号:US5049674A

    公开(公告)日:1991-09-17

    申请号:US454048

    申请日:1989-12-20

    CPC分类号: C07D401/12

    摘要: The novel compounds of the formulas I and I' ##STR1## wherein F is in 5 or 6 position and ##STR2## wherein in both formulas R is the group --CH.sub.2 OCOOR.sup.1, wherein R.sup.1 is a straight or branched alkyl containing 1-6 carbon atoms or benzyl, or R.sup.1 is the group ##STR3## --(CH.sub.2).sub.n COOH or --(CH.sub.2).sub.n SO.sub.3 H wherein n is 1-6 and physiologically acceptable salts thereof as well as intermediates, pharmaceutical compositions containing such compounds as active ingredient, and the use of the compounds in medicine.

    摘要翻译: 式I和I'的新颖化合物,其中F为5或6位且其中在两式中,R为基团-CH 2 OCOOR 1,其中R 1为含有1- 6个碳原子或苄基,或R1是基团,其中n是1-6,其生理学上可接受的盐以及中间体,含有活性的化合物的药物组合物是(CH 2)n COOH或 - (CH 2)n SO 3 H 成分,以及在药物中使用的化合物。